Restatement of Previously Reported Condensed Consolidated Financial Statements | Note 2. As previously disclosed on Form 8-K filed on November 16, 2021, the Company determined that the Company’s previously issued financial statements for the period ended March 31, 2021 should no longer be relied upon due to errors in such condensed consolidated financial statements related to revenue reported by Timios that provides title and agency services. The preparation of the Company’s condensed consolidated financial statements identified additional transactions and accounting practices not in accordance with U.S. GAAP. The following errors were identified as part of the restatement: A. The Company determined that it did not present Timios title and agency services revenue and the related cost of revenue in accordance with US GAAP on the condensed consolidated statement of operations, as premiums from title insurance policies written by independent agencies were presented on a gross basis and did not properly present revenue and cost of revenue net of commission costs. B. The Company discovered that it did not properly account for its investment in Technology Metals Market Limited (“TM2”) in accordance with the equity method of accounting. In addition, the Company determined that it incorrectly presented equity income (loss) on its equity method investments as a component of interest and other income (expense) on the condensed consolidated statements of operations rather than as a separate financial statement caption below income taxes. C. The Company discovered certain errors in determining the estimated fair value of acquired intangible assets in its purchase price allocation for its acquisitions. D. The Company determined that the errors in determining the estimated fair value of net assets acquired in its acquisitions resulted in an additional reduction to the Company’s deferred tax liabilities. E. The Company determined that it did not properly recognize income tax expense (benefit) for certain acquired entities subsequent to their respective acquisitions during the period ended March 31, 2021. The following reflects the restatement adjustments recorded in connection with the Company’s restatement of its condensed consolidated financial statements: Consolidated Balance Sheet March 31, 2021 As Previously Reported Adjustment As Restated Reference Assets Cash and cash equivalents $ 355,856 $ — $ 355,856 Accounts receivable, net 5,409 — 5,409 Available for sale security 15,155 — 15,155 Inventory 960 — 960 Prepaid expenses 6,400 — 6,400 Amount due from related parties 245 — 245 Other current assets 479 — 479 Current assets held for sale 7,068 — 7,068 Total current assets 391,572 — 391,572 Property and equipment, net 631 — 631 Intangible assets, net 92,525 (14,710) 77,815 C Goodwill 51,084 8,461 59,545 C Long-term investments 24,179 (178) 24,001 B Operating lease – right of use assets 9,338 (6,869) 2,469 * Other noncurrent assets 569 6,869 7,438 * Total assets $ 569,898 $ (6,427) $ 563,471 Liabilities and Stockholders’ Equity Accounts payable $ 9,978 $ — $ 9,978 Deferred revenue 2,225 — 2,225 Accrued salaries 4,831 — 4,831 Due to related party 1,235 — 1,235 Other current liabilities 7,112 135 7,247 *, E Current portion of lease liabilities 955 (318) 637 * Current contingent consideration 8,481 — 8,481 Note payable 869 — 869 Note payable – related party — — — Convertible promissory note to third parties 80,446 — 80,446 Asset retirement obligations 4,653 — 4,653 Total current liabilities 120,785 (183) 120,602 Asset retirement obligations — — — Deferred tax liabilities 1,290 (406) 884 C, D, E Operating lease liability – long term 8,485 (6,659) 1,826 * Non-current contingent consideration 8,630 — 8,630 Other long-term liabilities 1,175 6,659 7,834 * Total liabilities 140,365 (589) 139,776 Convertible redeemable preferred stock and Redeemable non-controlling interest: Series A Preferred stock 1,262 — 1,262 Redeemable non-controlling interest 7,600 — 7,600 Stockholders’ equity Preferred stock — — — Common stock, 419 — 419 Additional paid-in capital 761,155 — 761,155 Accumulated deficit (347,457) (5,838) (353,295) Accumulated other comprehensive income 784 — 784 Total IDEX stockholders’ equity 414,901 (5,838) 409,063 Noncontrolling interests 5,770 — 5,770 Total stockholders’ equity 420,671 — 414,833 Total liabilities and stockholders’ equity $ 569,898 $ (6,427) $ 563,471 * Represents revision for immaterial error correction – see Note 1. Condensed Consolidated Statement of Operations for the Three Months Ended March 31, 2021 As Restatement As Reported ** Adjustments Restated Reference Revenue - sales of products $ 4,547 $ — $ 4,547 Revenue - sales of services 28,162 (2,770) 25,392 A Total Revenue 32,709 (2,770) 29,939 Cost of revenue - sales of products 4,354 — 4,354 Cost of revenue - sales of services 17,513 (2,770) 14,743 A Total Cost of revenue 21,867 (2,770) 19,097 Gross Profit 10,842 — 10,842 Operating Expenses Selling, general and administrative 12,005 (154) 11,851 (1) Research and development 10 — 10 Professional fees 5,168 — 5,168 Impairment losses — — — Change -fair value of contingent consideration 494 — 494 Litigation settlement 5,000 — 5,000 Depreciation and amortization 1,128 — 1,128 Total operating expenses 23,805 (154) 23,651 Loss from operations (12,963) 154 (12,809) Interest and other expense: Interest expense, net (417) — (417) Loss on disposal of subsidiaries (212) — (212) Conversion expense — — — Gain on measurement of investments — — — Other income (expense), net (2) (154) (156) (1) Loss before income taxes and non-controlling interest (13,594) — (13,594) Income tax benefit 12,916 (5,660) 7,256 C,D,E Equity in loss of equity method investees (59) (178) (237) B Net loss (737) (5,838) (6,575) Deemed dividend related to warrant repricing — — — Net loss attributable to common shareholders (737) (5,838) (6,575) Net loss attributable to non-controlling interest 163 — 163 Net loss attributable to IDEX common shareholders $ (574) $ (5,838) $ (6,412) Earnings per share, basic & fully diluted $ (0.00) $ — $ (0.02) Weighted average number of common shares 391,131,793 0 391,131,793 ** Reflects the presentation of equity in loss of equity method as a separate financial statement caption below income tax benefit. (1) Reflects immaterial error correction for the classification of other income. Condensed Consolidated Statement of Comprehensive Income (Loss) for the Three Months ended March 31, 2021 As Restatement As Reported Adjustments Restated Notes Net loss $ (737) $ (5,838) $ (6,575) Other comprehensive income (loss), net of tax: Foreign currency translation adjustments (860) — (860) Comprehensive loss (1,597) (5,838) (7,435) Comprehensive loss (gain) attributable to non-controlling interest 552 — 552 Comprehensive loss attributable to IDEX $ (1,045) (5,838) $ (6,883) Condensed Consolidated Statement of Equity for the Three Months Ended March 31, 2021 Common Par Accumulated IDEX Total Stock Value APIC Deficit AOCI Equity NCI Equity Balance - March 31, 2021 (as reported) 419,469,800 $ 419 $ 761,155 $ (347,457) $ 784 $ 414,901 $ 5,770 $ 420,671 Adjustments Equity method investment (178) (178) (178) Income tax effects (5,660) (5,660) (5,660) Balance - March 31, 2021 (as restated) 419,469,800 $ 419 $ 761,155 $ (353,295) $ 784 $ 409,063 $ 5,770 $ 414,833 Condensed Consolidated Statement of Cash Flows for the Three Months Ended March 31, 2021 As Restatement As Reported Adjustments Restated Notes Cash flows from operating activities: Net loss $ (737) $ (5,838) $ (6,575) B, C, D,E Adjustments to reconcile net loss to net cash provided by operating activities: Share-based compensation 2,040 — 2,040 Depreciation and amortization 1,128 — 1,128 Non-cash interest expense 417 — 417 Allowance for doubtful accounts — — — Litigation settlement 5,000 (5,000) — (1) Income tax benefit (13,281) 5,660 (7,621) C,D,E Loss on disposal of subsidiaries 212 — 212 Equity in losses of equity method investees 59 178 237 B Issuance of common stock for professional fees — 1,162 1,162 (1) Gain on extinguishment of liability — — — Gain on remeasurement of investment — — — Impairment losses — — — Settlement of ROU operating lease liabilities — — — Change in fair value of contingent consideration 494 — 494 Change in assets and liabilities: Accounts receivable 2,600 — 2,600 Inventory 117 — 117 Prepaid expenses and other assets 1,653 1,653 Accounts payable 2,438 2,438 Deferred revenue (613) (613) Amount due to related parties 348 348 Accrued expenses, salary and other current liabilities 696 3,838 4,534 (1) Net cash provided by operating activities 2,571 — 2,571 Cash flows from investing activities: Acquisition of property and equipment (157) (157) Disposal of subsidiaries — — Acquisition of subsidiaries (55,265) (55,265) Investment in long-term investment (15,707) (15,707) Notes receivable — — Investment in debt securities (15,000) (15,000) Net cash used in investing activities (86,129) — (86,129) Cash flows from financing activities Proceeds from issuance of convertible notes 220,000 220,000 Proceeds from exercise of options and warrants 53,659 53,659 Proceeds from noncontrolling interest shareholder — — Borrowings from SBA PPP — — Repayment of amounts due to related parties — — Net cash provided by financing activities 273,659 — 273,659 Effect of exchange rate changes on cash (9) (9) Net increase in cash and cash equivalents 190,092 — 190,092 Cash and cash equivalents - beginning of period 165,764 — 165,764 Cash and cash equivalents - end of period $ 355,856 — $ 355,856 (1) Reflects immaterial error corrections for the classification of certain operating activities. |